An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season.
Orr
P
P
D000293:Adolescent; D000328:Adult; D026683:Advisory Committees; D002648:Child; D002675:Child, Preschool; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D009980:Influenza A virus / Q000472:pathogenicity; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D008297:Male; D008875:Middle Aged; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D009864:Ontario / Q000453:epidemiology; D011159:Population Surveillance; D014481:United States / Q000453:epidemiology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D009439:Neuraminidase